Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is well-positioned for growth due to its strong market position, diversified business segments, and focus on providing safe, high-quality care in the home. With its significant presence in the Medicaid market and preferred payer relationships, the company is well-insulated from potential reimbursement risks. Strong earnings growth and continued execution on its preferred payer strategy could drive multiple expansion for the company's stock. However, risks including reimbursement and labor market challenges should be closely monitored.

Bears say

Aveanna Healthcare Hldgs is a differentiated provider in the home healthcare industry with a strong focus on compliance, which is crucial for maintaining good standing with referral sources and high-demand nursing staff. The company's private-duty nursing platform gives it a significant competitive advantage as it provides specialized care to the vulnerable pediatric population, leading to a stable regulatory and reimbursement backdrop. However, risks related to government reimbursement, nurse availability, and policy changes pose challenges for the company's growth potential. While the company has a strong financial outlook with potential for deleveraging and cash flow generation, there may be downside risks related to reimbursement pressures and M&A execution. Ultimately, the success of Aveanna Healthcare will depend on its ability to navigate regulatory risks and continue to deliver high-quality care while driving growth and efficiency.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.